CorDx is a global biotechnology company specializing in the research, development, and manufacturing of rapid diagnostic tests and medical devices.
CorDx is a multi-national biotechnology organization dedicated to pushing the limits of innovation in global health. Headquartered in San Diego, California, the company specializes in the research, development, and manufacturing of In Vitro Diagnostic (IVD) rapid test kits. CorDx is widely recognized for its Tyfast line of diagnostics, including FDA Emergency Use Authorized (EUA) tests for COVID-19, Influenza A/B, and RSV.
Beyond respiratory diagnostics, CorDx produces a diverse portfolio of medical solutions, including pregnancy tests, drug detection kits, and various biomarker assays. With a vertically integrated supply chain and manufacturing capabilities partner facilities worldwide, CorDx delivers reliable, accessible, and accurate testing solutions to families, caregivers, and healthcare professionals in over 100 countries.
Neueste Handbücher von manuals+ Für diese Marke zusammengestellt.
Häufig gestellte Fragen zu Handbüchern, Registrierung und Support für diese Marke.
Detailed instructions include swabbing both nostrils, inserting the swab into the provided reagent tube, rotating it 10 times, and dispensing 3 drops into the sample well. Results are read between 10 and 30 minutes.
If the control line (C) is not visible, the test is invalid, even if other lines appear. You must re-test using a new swab and a new test cassette.
The test is authorized for self-collection in individuals aged 14 years or older. For children aged 2 to 13 years, an adult must collect the anterior nasal swab specimen.
A positive result is indicated by the presence of the Control line (C) along with one or more test lines (e.g., COV for COVID-19, Flu A, or Flu B). Any visible line in the test region should be considered positive.
The test kit should be stored at room temperature between 36°F and 86°F (2°C - 30°C). Ensure all components are at room temperature before testing.